Page 44 - Read Online
P. 44

Page 6 of 11                                    Montagne et al. Mini-invasive Surg 2020;4:17  I  http://dx.doi.org/10.20517/2574-1225.2019.74

               similar to those who were operated by an open approach (P = 0.56). Moreover, 30-day mortality was similar
                                     [39]
               (P = 0.69). Veronesi et al.  reported a multicenter retrospective cohort of patients with stage III NSCLC
               and operated by a RATS procedure in seven high volume centers. They reported 223 NSCLC, 32% of which
               were diagnosed cN2 preoperatively and 68% intraoperatively. The rate of conversion to thoracotomy was
               9.9%, and the rate of Grade 3 and more complications was 10.3%. For patients who received neoadjuvant
               chemotherapy, the rate of conversion to thoracotomy was 15%, the rate of Grade 3 and 4 complications
               was 12%, and all were resected with R0 margins. Overall 90-day mortality was 4% but no patient who
               received neoadjuvant chemotherapy died. Three-year overall survival was 61.2%, while 60.3% in the group
               of patients treated by neoadjuvant chemotherapy (P = 0.6).


               DISCUSSION
               In this mini-review, we compare short-term outcomes between lobectomy performed by minimally
               invasive VATS and RATS and lobectomy by open surgery. For several decades, VATS lobectomy has
               allowed better short-term outcomes compared to open surgery with at least the same long-term oncologic
               outcomes. These results were obtained by systematic review and meta-analysis of retrospective series and
               of some randomized controlled trials.

               Before discussing the reported results, the common points and differences among RATS, VATS, and open
               approaches are clarified. Together, there are three surgical approaches but two surgical feelings and two
               resection concepts for lung lobectomy.

               Regarding surgical feelings, also called haptic - force and tactile - feedback, compared to open surgery,
               VATS allows us to feel each tension exerted on the tissues, because we directly manipulate the tissue,
               lung, lymph nodes, and other structures. Conversely, the robotic platform is a robotic device guided by
               the surgeon using a digital interface. With the Da Vinci platform, we do not receive sensitive feedback in
               our hands. This lack of feedback is one of the criticisms made of this surgical tool. However, “when one
               feeling is lacking, we say that another develops”. Thus, surgeons who can no longer rely on touch see their
               eyes sharpen, becoming an extension of their hands. With training, they learn and feel the tension exerted
               on the tissue by seeing the latter exerted on the tissue, allowing them to exceed this limit. The surgeon
               assistants who expose and retract the lung will also help the operator surgeons, because they can feel
               the exerted tension on lung by the robot and thus the operator. Nevertheless, robotic surgery industries
               are studying haptic feedback, but each robotic system is different, thus each research system is different.
               Moreover, it is important to first understand how we perceive force and tactile information, because it will
                                                 [40]
               affect the way we design haptic displays .

               Regarding resection concepts, compared to VATS and the anterior approach - e.g., fissureless technique -
               RATS allows us to mimic open surgery techniques. The robotic platform allows thoracic surgeons to perform
               a lobectomy, as they would have done using an open approach. Conversely, the fissureless approach in
               VATS lobectomy is a necessary adaptation of a surgical technique.

                                   [18]
               In 2016, Bendixen et al.  published a randomized controlled trial comparing lobectomy by VATS and by
               anterior muscle sparing thoracotomy. For VATS, the authors observed less pain on Postoperative Day 1
               (P = 0.0012) and during the year after resection (P < 0.0001), as well as better quality of life according to
               EuroQol 5 Dimensions (EQ5D) (P = 0.014). Nevertheless, they found no difference between VATS and
               thoracotomy for postoperative Grade 3 and 4 adverse events, and quality of life according to the European
               Organisation for Research and Treatment of Cancer 30-item quality of life questionnaire (QLC-C30) (P =
                                                                                    [41]
               0.13). More recently, the first results of the randomized controlled VIOLET study  confirmed better short-
               term outcomes after lobectomy by VATS than by open surgery.
   39   40   41   42   43   44   45   46   47   48   49